Review Article
Adrenocortical Causes of Hypertension
| | PAC | PRA | PAC/PRA |
| | Medications | | | | | β-Adrenergic blockers | ↓ | ↓↓ | ↑(FP) | | Central α-2 agonists | ↓ | ↓↓ | ↑(FP) | | NSAIDs | ↓ | ↓↓ | ↑(FP) | | K+-wasting diuretics | →↑ | ↑↑ | ↓(FN) | | K+-sparing diuretics | ↑ | ↑↑ | ↓(FN) | | ACE inhibitors | ↓ | ↑↑ | ↓(FN) | | ARBs | ↓ | ↑↑ | ↓(FN) | | Ca2+ blockers (DHPs) | →↓ | ↑ | ↓(FN) | | Renin inhibitors | ↓ | ↓↑1 | ↑(FP)1 | | | | ↓ (FN) 1 | | Potassium status | | | | | Hypokalemia | ↓ | →↑ | ↓(FN) | | Potassium loading | ↑ | →↓ | ↑(FP) | | Dietary sodium | | | | | Sodium restricted | ↑ | ↑↑ | ↓(FN) | | Sodium loaded | ↓ | ↓↓ | ↑(FP) | | Advancing age | ↓ | ↓↓ | ↑ (FP) | | Other conditions | | | | | Renal impairment | → | ↓ | ↑(FP) | | PHA-2 | → | ↓ | ↑(FP) | | Pregnancy | ↑ | ↑↑ | ↓(FN) | | Renovascular HTN | ↑ | ↑↑ | ↓(FN) | | Malignant HTN | ↑ | ↑↑ | ↓ (FN) |
|
|